Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS.

MLA

Corboy, John R., et al. “Comment on 2018 American Academy of Neurology Guidelines on Disease-Modifying Therapies in MS.” Neurology, vol. 90, no. 24, June 2018, pp. 1106–12. EBSCOhost, https://doi.org/10.1212/WNL.0000000000005574.

APA

Corboy, J. R., Weinshenker, B. G., & Wingerchuk, D. M. (2018). Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS. Neurology, 90(24), 1106–1112. https://doi.org/10.1212/WNL.0000000000005574

Chicago

Corboy, John R, Brian G Weinshenker, and Dean M Wingerchuk. 2018. “Comment on 2018 American Academy of Neurology Guidelines on Disease-Modifying Therapies in MS.” Neurology 90 (24): 1106–12. doi:10.1212/WNL.0000000000005574.